mdlinx mdlinx
Latest (26) Full Text Articles (287) Focus on Fibromyalgia Article Summary

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: Results of a 5-year, randomized, placebo-controlled study
Osteoporosis International,  Clinical Article

Silverman SL et al. – The findings support a sustained anti-fracture effect of bazedoxifene on new vertebral fractures in postmenopausal osteoporotic women and on non-vertebral fractures in the higher-risk subgroup of women.

Methods

  • 4,216 postmenopausal women with osteoporosis enrolled
  • 2-year extension of 3-year, randomized, double-blind, placebo-controlled, phase 3 trial
  • In core study (N=7,492), subjects received bazedoxifene 20 or 40 mg/day, raloxifene 60 mg/day, or placebo
  • Raloxifene arm was discontinued after 3 years; subjects receiving bazedoxifene 40 mg were transitioned to bazedoxifene 20 mg after 4 years
  • 5-year findings reported for bazedoxifene 20 and 40/20 mg and placebo
  • Endpoints included incidence of new vertebral fractures (primary) and non-vertebral fractures, and changes in BMD and bone turnover markers

Results
  • At 5 years, the incidence of new vertebral fractures in the intent-to-treat population was significantly lower with bazedoxifene 20 mg (4.5%) and 40/20 mg (3.9%) versus placebo (6.8%; P<0.05), with relative risk reductions of 35% and 40%
  • Non-vertebral fracture incidence was similar among groups
  • In a subgroup of higher-risk women (n=1,324; femoral neck T-score ≤-3.0 and/or ≥1 moderate or severe or ≥2 mild vertebral fracture[s]), bazedoxifene 20 mg reduced non-vertebral fracture risk versus placebo (37%; P=0.06); combined data for bazedoxifene 20 and 40/20 mg reached statistical significance (34% reduction; P<0.05)
  • Bazedoxifene significantly increased BMD and reduced bone turnover versus placebo (P<0.05) and was generally safe and well tolerated

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Rheumatology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Rheumatology Articles

Last month's top read Top Articles of 2013

1 Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: A clinical observational study Rheumatology, February 11, 2014    Clinical Article

2 New discovery on Giant Cell Arteritis sheds light on cause Full Text ScienceDaily, January 21, 2014    Free full text

3 Ten common mistakes in the management of lupus nephritis American Journal of Kidney Diseases, January 3, 2014    Clinical Article

4 Autoantibodies and SLE- The threshold for disease Nature Reviews Rheumatology , December 5, 2013    Review Article

5 Vitamin D and cutaneous lupus erythematosus: Effect of vitamin D replacement on disease severity Lupus, February 12, 2014    Clinical Article

6 Effect of hydroxychloroquine on the lipid profile of patients with Sjogren's syndrome The Journal of Rheumatology, March 17, 2014    Clinical Article

7 3 Things Doctors Should Know About Obamacare U.S. News & World Report - Health, December 18, 2013

8 Interstitial lung disease in patients with rheumatoid arthritis: Spontaneous and drug induced Drugs, March 3, 2014    Clinical Article

9 New compound dramatically reduces joint inflammation Full Text ScienceDaily, December 12, 2013    Free full text

10 Treatment of asymptomatic hyperuricemia and prevention of vascular disease: A decision analytic approach The Journal of Rheumatology, March 4, 2014    Clinical Article

11 Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta? A systematic literature review and meta-analysis Annals of Rheumatic Diseases, January 6, 2014    Evidence Based Medicine    Review Article
Exclusive Author Commentary

12 Weather may truly affect arthritis pain Full Text Reuters Health News, February 13, 2014    Free full text

13 An allopurinol-controlled, multicenter, randomized, double-blind, parallel between-group, comparative study of febuxostat in Chinese patients with gout and hyperuricemia International Journal of Rheumatic Diseases, February 10, 2014    Clinical Article

14 Rituximab modulates IL-17 expression in the salivary glands of patients with primary Sjogren's syndrome Rheumatology, March 11, 2014    Clinical Article

15 Biomarkers in vasculitis Current Opinion in Rheumatology, December 4, 2013    Clinical Article

16 Late-onset neutropenia in patients with rheumatoid arthritis after treatment with rituximab The Journal of Rheumatology, March 17, 2014    Clinical Article

17 Up-titration of allopurinol in patients with gout Seminars in Arthritis and Rheumatism, February 3, 2014    Review Article

18 Cigarette smoking and risk of rheumatoid arthritis: A dose-response meta-analysis Arthritis Research & Therapy, March 7, 2014    Clinical Article

19 Intra articular injection with corticosteroids in patients with recent onset rheumatoid arthritis: subanalyses from the BeSt study Clinical Rheumatology, February 17, 2014    Clinical Article

20 Cancer mutation likely trigger of scleroderma Full Text ScienceDaily, December 9, 2013    Free full text

Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatologymore

Other Topics in Rheumatology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close